One injection of an experimental fat-burning drug from Roche Holding AG normalized diabetes in mice for more than a week and helped them lose weight, researchers said. The medicine may activate a rare type of fat that helps the body keep warm, according to the results published in Science Translational Medicine. The company-sponsored research suggests that treatments aimed at the so-called brown fat may be able to combat obesity-related diseases in a new way. The compound increased energy expenditure and lowered fat levels in the liver in addition to lowering blood sugar, the study said.
